ReviewCancer drug resistance (Alhambra, Calif.)2020

Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer.

Barbara Rath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.